title: Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.
abstract: The role of local tissue renin-angiotensin system (tRAS) activation in the cardiorenal metabolic syndrome (CRS) and type 2 diabetes mellitus (T2DM) is not well understood. To this point, we posit that early redox stress-mediated injury to tissues and organs via accumulation of excessive reactive oxygen species (ROS) and associated wound healing responses might serve as a paradigm to better understand how tRAS is involved. There are at least five common categories responsible for generating ROS that may result in a positive feedback ROS-tRAS axis. These mechanisms include metabolic substrate excess, hormonal excess, hypoxia-ischemia/reperfusion, trauma, and inflammation. Because ROS are toxic to proteins, lipids, and nucleic acids they may be the primary instigator, serving as the injury nidus to initiate the wound healing process. Insulin resistance is central to the development of the CRS and T2DM, and there are now thought to be four major organ systems important in their development. In states of overnutrition and tRAS activation, adipose tissue, skeletal muscle (SkM), islet tissues, and liver (the quadrumvirate) are individually and synergistically related to the development of insulin resistance, CRS, and T2DM. The obesity epidemic is thought to be the driving force behind the CRS and T2DM, which results in the impairment of multiple end-organs, including the cardiovascular system, pancreas, kidney, retina, liver, adipose tissue, SkM, and nervous system. A better understanding of the complex mechanisms leading to local tRAS activation and increases in tissue ROS may lead to new therapies emphasizing global risk reduction of ROS resulting in decreased morbidity and mortality.
authors.affiliation: Department of Internal Medicine, University of Missouri-Columbia School of Medicine, Columbia, Mo., USA.
authors.forename: Melvin R
authors.initials: MR
authors.lastname: Hayden
authors.forename: Kurt M
authors.initials: KM
authors.lastname: Sowers
authors.forename: Lakshmi
authors.initials: L
authors.lastname: Pulakat
authors.forename: Tejaswini
authors.initials: T
authors.lastname: Joginpally
authors.forename: Bennett
authors.initials: B
authors.lastname: Krueger
authors.forename: Adam
authors.initials: A
authors.lastname: Whaley-Connell
authors.forename: James R
authors.initials: JR
authors.lastname: Sowers
references.citation: Mol Cell Endocrinol. 2000 Feb 25;160(1-2):107-14
references.pmid: 10715544
references.citation: Miner Electrolyte Metab. 1998;24(6):389-99
references.pmid: 9930378
references.citation: Neurosurgery. 2007 Aug;61(2):390-5; discussion 395-6
references.pmid: 17806141
references.citation: Cardiology. 1991;79 Suppl 1:32-44
references.pmid: 1655263
references.citation: Circulation. 2004 Sep 14;110(11):1507-12
references.pmid: 15364819
references.citation: Hepatology. 2004 Sep;40(3):583-9
references.pmid: 15349896
references.citation: J Gastroenterol Hepatol. 1997 May;12(5):398-403
references.pmid: 9195388
references.citation: Am J Sports Med. 2005 May;33(5):745-64
references.pmid: 15851777
references.citation: Obesity (Silver Spring). 2008 Apr;16(4):770-6
references.pmid: 18239590
references.citation: Med Sci Monit. 2004 Dec;10(12):RA291-307
references.pmid: 15567993
references.citation: Transl Res. 2009 Jan;153(1):24-32
references.pmid: 19100955
references.citation: J Hepatol. 2006 Jan;44(1):197-208
references.pmid: 16274837
references.citation: Antioxid Redox Signal. 2007 Jul;9(7):891-910
references.pmid: 17516840
references.citation: Diabetes. 2004 Apr;53(4):989-97
references.pmid: 15047614
references.citation: J Cardiometab Syndr. 2006 Fall;1(5):326-33
references.pmid: 17679785
references.citation: Mayo Clin Proc. 1980 Jul;55(7):434-8
references.pmid: 7382552
references.citation: Int J Biochem Cell Biol. 2003 Jun;35(6):901-18
references.pmid: 12676175
references.citation: J Hepatol. 2008 Sep;49(3):417-28
references.pmid: 18486983
references.citation: J Cardiometab Syndr. 2007 Winter;2(1):70-5
references.pmid: 17684452
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13607-12
references.pmid: 15342908
references.citation: Am J Physiol. 1971 Dec;221(6):1733-7
references.pmid: 4330904
references.citation: J Am Acad Dermatol. 1985 Nov;13(5 Pt 1):701-25
references.pmid: 2416789
references.citation: Endocr Rev. 2003 Jun;24(3):261-71
references.pmid: 12788798
references.citation: Kidney Int. 1992 Jan;41(1):24-36
references.pmid: 1593860
references.citation: Anesth Analg. 2008 Dec;107(6):1946-52
references.pmid: 19020142
references.citation: J Lipid Res. 1979 Aug;20(6):705-15
references.pmid: 490049
references.citation: Cardiovasc Diabetol. 2003 Feb 12;2:2
references.pmid: 12628022
references.citation: Hypertension. 2001 Dec 1;38(6):1246-9
references.pmid: 11751697
references.citation: Am J Physiol. 1997 Feb;272(2 Pt 1):L320-34
references.pmid: 9124384
references.citation: Circulation. 1988 Jun;77(6 Pt 2):I4-13
references.pmid: 3286045
references.citation: J Gastroenterol Hepatol. 2008 Sep;23(9):1327-38
references.pmid: 18557800
references.citation: Diabetes. 2004 Jun;53(6):1509-16
references.pmid: 15161755
references.citation: Nephrol Dial Transplant. 2007 Jan;22(1):40-2
references.pmid: 16968730
references.citation: N Engl J Med. 1999 Sep 2;341(10):709-17
references.pmid: 10471456
references.citation: Am J Nephrol. 2005 Nov-Dec;25(6):553-69
references.pmid: 16210838
references.citation: Circulation. 1999 Feb 16;99(6):817-22
references.pmid: 9989969
references.citation: Cardiovasc Res. 1999 Aug 1;43(2):300-7
references.pmid: 10536660
references.citation: J Am Soc Hypertens. 2008 Jul-Aug;2(4):239-66
references.pmid: 20409906
references.citation: Diabet Med. 2003 Aug;20(8):607-21
references.pmid: 12873287
references.citation: J Cardiometab Syndr. 2006 Winter;1(1):36-40
references.pmid: 17675901
references.citation: Clin Exp Pharmacol Physiol. 2008 Aug;35(8):922-7
references.pmid: 18430060
references.citation: Oxid Med Cell Longev. 2010 Mar-Apr;3(2):109-21
references.pmid: 20716935
references.citation: Diabetes. 2003 Nov;52(11):2759-66
references.pmid: 14578294
references.citation: J Renin Angiotensin Aldosterone Syst. 2008 Jun;9(2):75-88
references.pmid: 18584583
references.citation: Cardiorenal Med. 2011;1(1):23-30
references.pmid: 22258463
references.citation: Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):6-12
references.pmid: 16377409
references.citation: Regul Pept. 2000 Jul 28;91(1-3):1-11
references.pmid: 10967197
references.citation: Cardiovasc Drugs Ther. 2001 Jan;15(1):79-87
references.pmid: 11504167
references.citation: Biol Pharm Bull. 2001 Aug;24(8):876-82
references.pmid: 11510477
references.citation: Int J Obes (Lond). 2008 Jan;32(1):112-20
references.pmid: 17637700
references.citation: Trends Endocrinol Metab. 2007 Jul;18(5):208-14
references.pmid: 17509892
references.citation: Am J Physiol Renal Physiol. 2007 Feb;292(2):F861-7
references.pmid: 17032939
references.citation: J Cardiovasc Pharmacol. 1987;10 Suppl 7:S1-8
references.pmid: 2485038
references.citation: Hypertens Res. 2008 Feb;31(2):175-84
references.pmid: 18360035
references.citation: Endocrinology. 2008 Nov;149(11):5643-53
references.pmid: 18653711
references.citation: J Cardiometab Syndr. 2006 Winter;1(1):29-35
references.pmid: 17675902
references.citation: Biochem Biophys Res Commun. 1993 Dec 30;197(3):1458-64
references.pmid: 7904159
references.citation: Hypertension. 2000 Jun;35(6):1270-7
references.pmid: 10856276
references.citation: Hypertension. 1991 Mar;17(3):270-7
references.pmid: 1999357
references.citation: JOP. 2002 Jul;3(4):86-108
references.pmid: 12110767
references.citation: Proc Natl Acad Sci U S A. 1983 Dec;80(24):7405-9
references.pmid: 6324167
references.citation: Trends Cardiovasc Med. 1992 May-Jun;2(3):94-9
references.pmid: 21239267
references.citation: J Cardiometab Syndr. 2006 Summer;1(3):197-203
references.pmid: 17679833
references.citation: Am J Hypertens. 2004 Nov;17(11 Pt 2):16S-20S; quiz A2-4
references.pmid: 15539106
references.citation: Nat Med. 2009 Aug;15(8):940-5
references.pmid: 19633655
references.citation: J Cardiometab Syndr. 2006 Winter;1(1):16-24
references.pmid: 17675904
references.citation: Cardiovasc Diabetol. 2002 Sep 27;1:3
references.pmid: 12392600
references.citation: Nutr Metab (Lond). 2004 Oct 19;1(1):10
references.pmid: 15507132
references.citation: Am J Med. 1988 Mar 11;84(3A):28-36
references.pmid: 3064597
references.citation: Minerva Endocrinol. 1999 Jun;24(2):77-81
references.pmid: 10941427
references.citation: Circulation. 1994 Jan;89(1):493-8
references.pmid: 8281685
references.citation: J Clin Invest. 1985 Jul;76(1):149-55
references.pmid: 3894418
references.citation: Curr Alzheimer Res. 2005 Jan;2(1):29-35
references.pmid: 15977987
references.citation: J Renin Angiotensin Aldosterone Syst. 2002 Dec;3(4):243-6
references.pmid: 12584667
references.citation: J Cardiometab Syndr. 2006 Winter;1(1):47-52
references.pmid: 17675899
references.citation: Hypertension. 2002 Nov;40(5):609-11
references.pmid: 12411451
references.citation: J Am Soc Nephrol. 2008 Dec;19(12):2254-61
references.pmid: 18776124
references.citation: J Physiol. 2007 Apr 1;580(Pt 1):31-7
references.pmid: 17218353
references.citation: J Lipid Res. 1979 Aug;20(6):691-704
references.pmid: 490048
references.citation: J Biol Chem. 1985 Dec 5;260(28):14938-44
references.pmid: 2999099
references.citation: J Hypertens Suppl. 1992 Dec;10(7):S13-26
references.pmid: 1337911
references.citation: Ther Clin Risk Manag. 2007 Dec;3(6):1153-63
references.pmid: 18516264
references.citation: Endocrinology. 2007 Aug;148(8):3773-80
references.pmid: 17494996
references.citation: Genome Biol. 2008 Jan 21;9(1):R14
references.pmid: 18208606
references.citation: Diabetes. 1988 Jun;37(6):667-87
references.pmid: 3289989
references.citation: Circulation. 1994 Jan;89(1):458-70
references.pmid: 8281681
references.citation: Biochem Pharmacol. 2006 Nov 30;72(11):1493-505
references.pmid: 16723122
references.citation: ILAR J. 2006;47(3):225-33
references.pmid: 16804197
references.citation: J Cardiometab Syndr. 2008 Winter;3(1):55-9
references.pmid: 18326977
references.citation: Physiol Rev. 1997 Oct;77(4):1033-79
references.pmid: 9354811
references.citation: Indian J Exp Biol. 2003 Jul;41(7):669-81
references.pmid: 15255370
references.citation: Am J Physiol. 1978 Sep;235(3):E279-86
references.pmid: 696822
references.citation: Exp Biol Med (Maywood). 2008 Sep;233(9):1109-23
references.pmid: 18641056
references.citation: Diabetologia. 2004 Feb;47(2):240-8
references.pmid: 14722647
references.citation: Nutr J. 2004 May 10;3:4
references.pmid: 15134582
references.citation: Br J Radiol. 2007 Sep;80 Spec No 1:S23-31
references.pmid: 17704323
references.citation: J Am Coll Cardiol. 2003 Feb 19;41(4):666-73
references.pmid: 12598081
references.citation: Int J Biochem Cell Biol. 2003 Jun;35(6):838-46
references.pmid: 12676170
references.citation: Microcirculation. 2005 Dec;12(8):627-36
references.pmid: 16284004
references.citation: Chest. 1991 Mar;99(3 Suppl):57S-60S
references.pmid: 1997277
references.citation: J Biol Chem. 2000 Apr 7;275(14):10648-54
references.pmid: 10744761
references.citation: Am J Physiol Endocrinol Metab. 2008 Jul;295(1):E110-6
references.pmid: 18445755
references.citation: Physiol Rev. 2006 Jul;86(3):747-803
references.pmid: 16816138
references.citation: J Clin Invest. 1987 Aug;80(2):415-24
references.pmid: 3301899
references.citation: Obes Rev. 2003 Feb;4(1):43-55
references.pmid: 12608526
references.citation: Diabetes. 2006 Jul;55(7):2106-14
references.pmid: 16804082
references.citation: Med Sci Monit. 2003 Jul;9(7):SR35-52
references.pmid: 12883468
references.citation: JOP. 2007 Nov 09;8(6):725-38
references.pmid: 17993725
references.citation: Trends Endocrinol Metab. 2000 Nov;11(9):351-6
references.pmid: 11042464
references.citation: Surg Endosc. 2001 Nov;15(11):1315-9
references.pmid: 11727142
references.citation: Circulation. 1997 Sep 16;96(6):1976-82
references.pmid: 9323089
references.citation: J Cardiometab Syndr. 2008 Fall;3(4):234-43
references.pmid: 19040593